Serum Polychlorinated Biphenyl Burden and Prevalent Cardiovascular Disease in U.S. Adults: A Cross-Sectional Analysis Using Evidence from NHANES 1999–2002

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Background: Polychlorinated biphenyls (PCBs) persist in the environment and have been associated with cardiovascular disease (CVD). We examined whether routine cardiometabolic biomarkers statistically accounted for this association. Methods: This cross-sectional analysis used NHANES 1999–2002 data for 2815 adults aged 20 years or older. Lipid-adjusted total PCB burden was the sum of 21 congeners. Survey-weighted logistic regression estimated odds ratios for prevalent CVD, restricted cubic splines examined the exposure–response shape, and mediator-specific structural equation models evaluated indirect and residual pathways through CRP, HbA1c, waist circumference, central obesity, the total cholesterol/HDL ratio, and a binary high-ratio measure. Results: Weighted mean total PCB burden was 234.6 ng/g lipid, and weighted CVD prevalence was 8.9%. A 1-unit increase in the natural log of total PCB burden was associated with higher odds of prevalent CVD after full adjustment (aOR = 1.36, 95% CI: 1.01–1.84). Coronary heart disease and angina showed the clearest subtype associations. The spline analysis did not detect nonlinearity. Indirect estimates through CRP, waist circumference, and the TC/HDL ratio were negative, which is consistent with statistical suppression; estimates through the other biomarkers were small and imprecise. Conclusions: Higher serum PCB burden was associated with prevalent CVD after adjustment for major demographic and cardiometabolic factors. In cross-sectional pathway models, routine biomarkers did not account for most of this association. Longitudinal studies are needed before these statistical pathways can be interpreted as causal mechanisms.

This publication has 27 references indexed in Scilit: